Description

4-[4-(Dimethylamino)Phenyl]-2,7,7-Trimethyl-n-(6-Methyl-2-Pyridinyl)-5-Oxo-1,4,5,6,7,8-Hexahydro-3-Quinolinecarboxamide is a complex heterocyclic organic compound with a fused quinoline and pyridine structure, serving as a key advanced intermediate in pharmaceutical synthesis. This compound matters for its role in the development of novel therapeutic agents, particularly as a precursor for active pharmaceutical ingredients (APIs) with targeted biological activity. It is primarily needed by research institutions and pharmaceutical manufacturers engaged in the discovery and production of specialized drug candidates.

Application

• Pharmaceutical Intermediate: A critical building block in the synthesis of novel drug candidates, particularly in research for central nervous system (CNS) or anti-inflammatory therapies.
• Chemical Research & Development: Used as a sophisticated scaffold in medicinal chemistry for structure-activity relationship (SAR) studies and lead optimization.
• Academic Research: Serves as a reference standard or starting material in university and institutional labs studying heterocyclic chemistry and organic synthesis pathways.
• Contract Manufacturing (CMO): Supplied to contract development and manufacturing organizations (CDMOs) for custom synthesis projects and pilot-scale API production.
• Biochemical Research: Potential use in developing enzyme inhibitors or receptor modulators due to its complex, multi-functional molecular structure.

Basic Information

Item	Details
Product Name	4-[4-(Dimethylamino)Phenyl]-2,7,7-Trimethyl-n-(6-Methyl-2-Pyridinyl)-5-Oxo-1,4,5,6,7,8-Hexahydro-3-Quinolinecarboxamide
CAS No.	354118-83-5
Molecular Formula	C27H32N4O2
Molecular Weight	444.57 g/mol
Synonyms	4-[4-(Dimethylamino)phenyl]-2,7,7-trimethyl-N-(6-methylpyridin-2-yl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxamide; 354118-83-5; 4-(4-(Dimethylamino)phenyl)-2,7,7-trimethyl-N-(6-methylpyridin-2-yl)-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxamide; Hexahydroquinolinecarboxamide derivative; A complex dimethylamino phenyl trimethyl quinolinecarboxamide.
EINECS	Contact for details

Quality Control

Our 4-[4-(Dimethylamino)Phenyl]-2,7,7-Trimethyl-n-(6-Methyl-2-Pyridinyl)-5-Oxo-1,4,5,6,7,8-Hexahydro-3-Quinolinecarboxamide is produced under strict quality management systems. Every batch undergoes rigorous analytical testing, including HPLC for purity and identity confirmation, to ensure it meets the high standards required for pharmaceutical research. Certificates of Analysis (COA) detailing batch-specific results are available upon request to support your quality assurance and regulatory documentation.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at a controlled room temperature (typically 15-25°C). Keep the container tightly sealed when not in use to protect the light-sensitive material from degradation.

Specification

Item	Specification
Appearance	Off-white to light yellow crystalline powder
Identification (IR)	Conforms to structure
Purity (HPLC)	≥ 97.0%
Loss on Drying	≤ 1.0%
Residue on Ignition	≤ 0.5%
Single Unknown Impurity (HPLC)	≤ 1.0%
Total Impurities (HPLC)	≤ 3.0%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.